0002044524-24-000001.txt : 20241114 0002044524-24-000001.hdr.sgml : 20241114 20241114141229 ACCESSION NUMBER: 0002044524-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 EFFECTIVENESS DATE: 20241114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Esanik Therapeutics, Inc. CENTRAL INDEX KEY: 0002044524 ORGANIZATION NAME: IRS NUMBER: 474281312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-529423 FILM NUMBER: 241460269 BUSINESS ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-209-8885 MAIL ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0708 D LIVE 0002044524 Esanik Therapeutics, Inc. 7 RAPPS RUN DRIVE MALVERN PA PENNSYLVANIA 19355 610-209-8885 DELAWARE None None Corporation true John Mel Sorensen 7 Rapps Run Drive Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2024-10-31 false true false 0 3278915 3278915 0 false 4 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Esanik Therapeutics, Inc. /s/ John Mel Sorensen John Mel Sorensen President 2024-11-14